Trial intelligence / Profile preview

Etomidate versus propofol for sedated upper endoscopy in obese adults

ChiCTR-TRC-13003162Phase 4Completed

Sponsor
Army Specialized Medical Center
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of etomidate and propofol in No canonical single disease; term refers to multiple upper gastrointestinal tract diseases (2 arms), sponsored by Army Specialized Medical Center. Primary endpoints: Hemodynamic changes and Adverse reactions. Started Mar 2013; status: completed.

02

Drugs

etomidatepropofol
03

Conditions

No canonical single disease; term refers to multiple upper gastrointestinal tract diseases

Beyond the preview

Go deeper on ChiCTR-TRC-13003162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call